Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection

  • Read more about Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection

Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)

  • Read more about Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)

VEGF and SFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease

  • Read more about VEGF and SFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease

Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

  • Read more about Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

The COVID-RASi Trial (COVID-19)

  • Read more about The COVID-RASi Trial (COVID-19)

French Cohort of COVID-19 Patients With Post-intensive Care Syndrome

  • Read more about French Cohort of COVID-19 Patients With Post-intensive Care Syndrome

Late Clinical Events Associated With COVID-19 Infection

  • Read more about Late Clinical Events Associated With COVID-19 Infection

Myeloid Cells in Patients With Covid-19 Pneumonia

  • Read more about Myeloid Cells in Patients With Covid-19 Pneumonia

Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

  • Read more about Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

  • Read more about GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 180
  • Page 181
  • Page 182
  • Page 183
  • Current page 184
  • Page 185
  • Page 186
  • Page 187
  • Page 188
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA